Literature DB >> 2982216

Limitations of computed tomography following excisional biopsy of soft tissue sarcomas.

T M Hudson, M Schakel, D S Springfield.   

Abstract

Twenty-one patients were evaluated by computed tomography (CT) following complete or incomplete excisional biopsy of soft tissue sarcomas. Since the surgical margins were inadequate, additional treatment was required, and CT was intended to identify and delineate any residual tumor. Thirteen patients had no palpable mass in the operative area. In these, eleven CTs showed no tumor, but microscopic tumor was found in seven. The other two CTs showed masses, but both proved to be hematomas. Eight patients had palpable masses and seven proved to be residual tumor. Of these, two CTs failed to show the residual tumor. Five CTs correctly identified residual tumor, but two of them failed to show the entire tumor extent. Computed tomography did not correctly predict the presence or absence of microscopic residual tumor when there was no palpable mass, and was at least partly inaccurate in delineating residual tumor in four of eight patients with palpable masses.

Entities:  

Mesh:

Year:  1985        PMID: 2982216     DOI: 10.1007/bf00349094

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  19 in total

1.  The principles and technique of resection of soft parts for sarcoma.

Authors:  L BOWDEN; R J BOOHER
Journal:  Surgery       Date:  1958-12       Impact factor: 3.982

2.  Clinical aspects of soft-tissue tumors.

Authors:  R L CLARK; R G MARTIN; E C WHITE; J W OLD
Journal:  AMA Arch Surg       Date:  1957-06

3.  End results in the treatment of sarcomata of the soft somatic tissues.

Authors:  G T PACK
Journal:  J Bone Joint Surg Am       Date:  1954-04       Impact factor: 5.284

4.  Soft tissue tumours: their natural history and treatment.

Authors:  S CADE
Journal:  Proc R Soc Med       Date:  1951-01

Review 5.  Computed tomography in bone and soft tissue neoplasm: application and pathologic correlation.

Authors:  D I Rosenthal
Journal:  Crit Rev Diagn Imaging       Date:  1982

6.  Nuclear magnetic resonance imaging of a fibrosarcoma tumor implanted in the rat.

Authors:  K L Moon; P L Davis; L Kaufman; L E Crooks; P E Sheldon; T Miller; A C Brito; J C Watts
Journal:  Radiology       Date:  1983-07       Impact factor: 11.105

7.  Comparison of computed tomography and angiography in the evaluation of soft tissue tumors of the extremities.

Authors:  L Ekelund; K Herrlin; A Rydholm
Journal:  Acta Radiol Diagn (Stockh)       Date:  1982

8.  CT of soft-tissue tumors.

Authors:  N Egund; L Ekelund; M Sako; B Persson
Journal:  AJR Am J Roentgenol       Date:  1981-10       Impact factor: 3.959

9.  The role of computed tomography in the management of soft tissue sarcomas.

Authors:  S J Golding; J E Husband
Journal:  Br J Radiol       Date:  1982-10       Impact factor: 3.039

10.  Angiography in the management of musculoskeletal tumors.

Authors:  T M Hudson; G Haas; W F Enneking; I F Hawkins
Journal:  Surg Gynecol Obstet       Date:  1975-07
View more
  5 in total

1.  MR imaging in the assessment of residual tumour following inadequate primary excision of soft tissue sarcomas.

Authors:  A M Davies; A Mehr; S Parsonage; N Evans; R J Grimer; P B Pynsent
Journal:  Eur Radiol       Date:  2003-10-14       Impact factor: 5.315

2.  Biopsy problems in patients with musculoskeletal tumours.

Authors:  B Waldron; R M Moran; B J Hurson
Journal:  Ir J Med Sci       Date:  1990-08       Impact factor: 1.568

3.  The role of magnetic resonance imaging in the evaluation of Ewing sarcoma. A report of 27 cases.

Authors:  C Frouge; D Vanel; C Coffre; D Couanet; G Contesso; D Sarrazin
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

4.  Magnetic resonance imaging of bone and soft tissue tumors: early experience in 31 patients compared with computed tomography.

Authors:  T M Hudson; D J Hamlin; W F Enneking; H Pettersson
Journal:  Skeletal Radiol       Date:  1985       Impact factor: 2.199

5.  Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas.

Authors:  M H Schwarzbach; A Dimitrakopoulou-Strauss; F Willeke; U Hinz; L G Strauss; Y M Zhang; G Mechtersheimer; N Attigah; T Lehnert; C Herfarth
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.